Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-020912
Filing Date
2020-07-31
Accepted
2020-07-31 18:35:40
Documents
1
Period of Report
2020-07-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6196
  Complete submission text file 0000899243-20-020912.txt   7654
Mailing Address 139 MAIN STREET, SUITE 500 CAMBRIDGE MA 02142
Business Address 139 MAIN STREET, SUITE 500 CAMBRIDGE MA 02142 (617) 433-2605
Allovir, Inc. (Issuer) CIK: 0001754068 (see all company filings)

EIN.: 831971007 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ALLOVIR, INC. 139 MAIN STREET, SUITE 500 CAMBRIDGE MA 02142
Business Address
Atillasoy Ercem (Reporting) CIK: 0001818802 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39409 | Film No.: 201067316